Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Pancragen: Evidence Summary
Evidence summary for Pancragen across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Pancragen overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Pancreatic function | Tier D | 0 | No human trials exist; rodent studies report improved pancreatic function but remain unverified |
| Metabolic regulation | Tier D | 0 | Animal data suggests glucose normalization effects but no human translation has been attempted |